Purpose: To determine the preference of members of the American Glaucoma Society for the use of antifibrotic agents (mitomycin C or 5-fluorouracil or both) and glaucoma drainage devices in ten clinical settings.
Materials and Methods: Voluntary written survey of the American Glaucoma Society.
Results: American Glaucoma Society (AGS) members continue to report preference for mitomycin C use in ten clinical settings. The percent usage for glaucoma drainage devices has increased in poor prognosis scenarios including the following: neovascular glaucoma, previous failed trabeculectomy, previous ECCE/ICCE, previous PKP, previous scleral buckling surgery, and uveitic glaucoma. However, trabeculectomy and MMC continue to be more likely employed for surgical management.
Conclusion: Despite the long-term complications of bleb-related infections, no statistically significant shift in preference away from MMC use or reduction in the concentration of drug delivery was observed since the 1996 survey.
From the Department of Ophthalmology, University of Miami School of Medicine, Miami, Florida, USA.
This study was supported by Research to Prevent Blindness.
Presented at the 2003 Meeting of the American Glaucoma Society, San Francisco, California, March 7, 2003.
Reprints: Richard K. Parrish II, Department of Ophthalmology, University of Miami School of Medicine, 900 NW 17th St., Miami, FL 33143 (e-mail: firstname.lastname@example.org).